摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-((3R,4S,5S,6R)-3,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yl)-benzamide | 32442-81-2

中文名称
——
中文别名
——
英文名称
N-((3R,4S,5S,6R)-3,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yl)-benzamide
英文别名
N-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzamide
N-((3R,4S,5S,6R)-3,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yl)-benzamide化学式
CAS
32442-81-2
化学式
C13H17NO6
mdl
——
分子量
283.281
InChiKey
SPYSOSUFGSNSMY-TWEVDUBQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.9
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    119
  • 氢给体数:
    5
  • 氢受体数:
    6

文献信息

  • [EN] NOVEL OLIGOSACCHARIDE GLYCOSIDES HAVING MAMMALIAN IMMUNOSUPPRESSIVE AND TOLEROGENIC PROPERTIES<br/>[FR] NOUVEAUX GLYCOSIDES OLIGOSACCHARIDIQUES AYANT DES PROPRIETES IMMUNOSUPPRESSIVES ET TOLEROGENES CHEZ LES MAMMIFERES
    申请人:GLYCOMED, INC.
    公开号:WO1997018222A2
    公开(公告)日:1997-05-22
    (EN) Disclosed are novel oligosaccharide glycosides having mammalian immunosuppressive and tolerogenic properties, pharmaceutical compositions containing such oligosaccharide glycosides and methods of using such oligosaccharide glycosides to modulate cell-mediated immune responses in a mammal.(FR) L'invention concerne de nouveaux glycosides oligosaccharidiques possédant des propriétés immunosuppressives et tolérogènes chez les mammifères, des compositions pharmaceutiques les contenant et des procédés d'utilisation de ces glycosides pour moduler les réponses immunes induites par les cellules chez un mammifère.
  • [EN] MONOSACCHARIDE DERIVATIVES<br/>[FR] DERIVES DE MONOSACCHARIDES
    申请人:UNIV DUBLIN
    公开号:WO2003018598A2
    公开(公告)日:2003-03-06
    Monosaccharide (pyranoside) conjugates of the formula have been found to be useful as enhancers and/or inhibitors of heparin binding to FGF. The compounds have the potential to be useful in regenerative medicine or for treatment of pathological disease associated with FGF activity or as glycoprocessing inhibitors. In particular the compounds are potential modulators of fibroblast growth factors (FGFs) and fibronectin, as mitogenic agents and as inhibitors of endothelial cell survival.
查看更多